Biotech founders getting ready to raise
- Spin-outs and first-time founders
- Scientists who want the business case checked before the first investor meeting
- Teams who want to know which investors fit before they write to anyone
Biotech funding, rethought.
SeriesBio is a two-sided marketplace for early-stage biotech funding. Founders learn which gaps to close before they pitch. Investors get deal flow that fits their thesis.
1stplace at the DevDay Community Hackathon: Berlin Get early accessWhy early biotech rounds stall
- Diligence is specialist.Biotech investors look at the science, the IP and the path to the clinic long before the market. Many founders find that out in the meeting.
- Great science isn't always a business case.Investors need a business case too. Scientific founders often get that feedback too late.
- Cold outreach burns time.Founders write to funds whose focus never fit their company.
- Good deals stay out of sight.Promising startups outside an investor's network rarely reach the partner who would back them.
Scored the way biotech VCs read a deck
SeriesBio turns your non-confidential deck into a Startup CV and scores it area by area, the way a biotech investor reads it. Strengths and gaps are visible at a glance.
- Science & dataMechanism, preclinical evidence and how reproducible it is86
- TeamScientific, clinical and operating depth78
- IP & freedom to operatePatent position and what could block you55
- Regulatory pathRoute to the clinic and key milestones61
- CMC & manufacturingProcess, scale-up and clinical supply38
- Market & businessIndication size, pricing and exit story72
0–100
One readiness score, with every gap ranked by how much risk it adds for an investor.
Know what investors will ask. Before they ask.
Upload your deck and SeriesBio scores it across the areas a biotech partner checks. You see what is strong, what is missing and which fix lowers investor risk the most.
- Start with your deck. Upload a non-confidential PDF and SeriesBio drafts your Startup CV from it.
- Close the right gaps first. Each gap is ranked by how much risk it adds for an investor.
- Business advice in plain words. Pricing, market and round logic, written for scientists.
- Investors that fit. A shortlist of investors whose focus fits your company. Every gap you close can open up more funds.
Helixa TherapeuticsAAV gene therapy · Seed · Berlin
Fictional example
67Readiness
Close first
- No scale-up plan for vector productionName a CDMO and the batch size you need for a Phase IHigh risk
- Freedom to operate on the capsid is unclearAdd an FTO opinion or a licence plan for the capsidHigh risk
- No scientific advice meeting plannedShow when you will meet EMA or FDA before the CTAMedium
14 investors fit this round
Deal flow filtered by your thesis
Tell SeriesBio what you back. Every startup that comes through gets a fit score against your thesis and a readiness score you can open, so you meet better-prepared companies sooner.
- Your thesis, as filters. Tell SeriesBio what you invest in and the readiness you expect.
- A fit score per startup. See why it fits and where it doesn't.
- Diligence starts on page one. Open gaps are flagged before the first call.
Your deal flow3 new this week
Fictional example
ModalityCell & gene therapy
StagePre-seed · Seed
RegionDACH · Nordics
Ticket€0.5–3M
94Fit
Helixa Therapeutics
AAV gene therapy for inherited retinal disease
88Fit
Corvane Bio
Off-the-shelf CAR-NK cells for solid tumours
81Fit
Nordlys RNA
Base editing for rare liver disorders
Both sides say yes. Then you talk.
No cold emails and no inbox nobody reads. A founder and an investor only match when both have shown interest. The chat opens with the Startup CV and readiness report already shared.
- Confidential data stays with you. You decide what investors see, and when.
Match & chatFounder and investor after both said yes
Fictional example
HT
Helixa TherapeuticsFounder · Seed
NV
Nordvik Life VenturesInvestor · CGT seed
It's a match · today
Your retinal data is strong. Before a partner meeting, can you walk us through the CMC plan?Lena, Nordvik · 10:14
CMC plan v2, with CDMO quoteHelixa · 10:31
Perfect. Thursday at 3pm?Lena, Nordvik · 10:33
How it works
- 1
Upload your deck
A non-confidential PDF is all you need to start.
- 2
Get your score
Your Startup CV and readiness in every diligence area, with strengths and gaps.
- 3
Close the gaps
Work down the list, ranked by how much each gap worries investors.
- 4
Match and talk
Show interest in funds that fit. When they say yes too, the chat opens.
- 1
Set your thesis
Tell SeriesBio what you invest in.
- 2
Review deal flow
Startups ranked by fit, each with its readiness report.
- 3
Show interest
One click. The founder sees it only if they are interested in you too.
- 4
Match and talk
Chat with the Startup CV and report in one place, then book the meeting.
First place on day one.
SeriesBio started at the DevDay Community Hackathon: Berlin in October 2026. In a single day we built a clickable prototype with the Startup CV, readiness score, advisory and two-way matching, and won first place.
Now we are building the full platform with the first founders and investors who join early access.
Get early accessDevDay Community Hackathon: BerlinOctober 2026
1st
Place- Clickable prototype built in one day
- Founder view and investor view
- Readiness score, advisory and two-way matching
Built for both sides of the table
Investors with a life‑science focus
- VCs, CVCs and angels
- Funds that want better-prepared companies in the pipeline
- Partners who want open gaps flagged before the first call
Join early access
We are onboarding the first founders and investors. Leave your email and tell us which side you're on.